Abstract
Key Points 1 Historical perspective of donor allocation to patients with fulminant hepatic failure (FHF). 2 Predicting prognosis in patients with FHF using the London and Clichy criteria. 3 Model for end‐stage liver disease (MELD) is a predictor of mortality in patients with FHF. 4 Outcomes of adults listed as Status 1 in the United States. 5 Outcomes of pediatric candidates listed as Status 1 in the United States. 6 Proposed redefinition for Status 1 in adult and pediatric candidates. (Liver Transpl 2004;10:S17–S22.)